100% Pharma Tariffs : How it will impact Indian pharma ?
United States has announced steep tariffs of up to 100% on patented drugs, sparing generics and biosimilars. This move is ...
United States has announced steep tariffs of up to 100% on patented drugs, sparing generics and biosimilars. This move is ...
Trump government is getting ready to put very high tariffs of 100% on some imported medicines. The idea is to ...
Kotak Institutional Equities remains positive about the Indian pharmaceutical sector, even as US tariff uncertainties loom. They believe leading companies ...
Neuland Laboratories, a Hyderabad-based pharmaceutical company, has delivered massive returns in 13 years. In 2010, its share price was around ...
Suven Pharmaceuticals' shares surged 14% to Rs 1,328.20 on the BSE during Thursday's trade. This rise is due to heavy ...
HSBC has analyzed the potential impact of a 10% tariff on Indian pharmaceutical companies' earnings per share (EPS) for the ...
India plans to increase its pharmaceutical exports tenfold, targeting $350 billion by 2047. The country will focus on specialty generics, ...
On February 10, 2025, the Nifty Pharma index fell by 2%, hitting an intraday low of 21,634.75. Analysts cited three ...